英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

amoeboid    
a. 似变形虫的

似变形虫的

amoeboid
adj 1: like an amoeba (especially in having a variable irregular
shape) [synonym: {ameboid}, {amoeboid}]


请选择你想看的字典辞典：
单词字典翻译
amoeboid查看　amoeboid　在百度字典中的解释百度英翻中〔查看〕
amoeboid查看　amoeboid　在Google字典中的解释Google英翻中〔查看〕
amoeboid查看　amoeboid　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Biotech Companies: How Your Pipeline Influences Investors
    Biotech focuses on new drug development and clinical research to treat diseases and health conditions The “pipeline” refers to the stages biotech companies must pass through to move on to the next one As outlined below, four main phases make up the pipeline Source: ILD Collaborative Naturally, for biotech companies, the pipeline is
  • VC funding trends in biotechnology | McKinsey
    VC investors provided $3 billion in funding for this group in 2022 As the impact of these platforms grows, early-stage start-ups are focusing their efforts on the following areas: Optimizing mRNA technology Given mRNA vaccines’ significant contribution to curbing the COVID-19 pandemic, an interest in optimizing the platform continues to grow
  • Valuation and Returns of Drug Development Companies: Lessons . . .
    This observation is coherent with expectations given that the pre-clinical drug discovery process and early clinical development are associated with several unknown factors and incur higher attrition rates than late-stage clinical development [11, 16] The more pre-clinical and clinical data are available on a drug, the lower the uncertainty
  • Biotech Investing: Most Profitable Stages of Clinical Trials
    This is one reason why Phase 2 is the real sweet spot for biotech investing… Phase 2 Trials: A Profitable Time to Be Involved in Biotech Stocks Phase 2 is often the most profitable time to be involved in a small cap biotech stock Many times, Phase 2 results are positive Sometimes it’s because the drug works
  • Funding considerations for early-stage biopharma - Cytiva
    Seeking dilutive capital, in which new investors invest in the company and dilute the ownership percentage of existing investors and employees, can keep therapeutic asset development moving forward During the period of translational research and proof-of-concept studies, investors care most about validating and de-risking the technology
  • Accelerating Biotech Success: Early-Stage Development . . .
    New rules and strategies for emerging biotech and pharma to secure funding for tailored early-stage solutions There has been a critical shift in funding dynamics and the biotech landscape is demanding a more integrated approach to early-stage asset development In an era where clinical data and a compelling commercial story are non-negotiable, companies need s
  • 2025 Trends in Biotech Venture Capital Funding - excedr. com
    Late-stage biotech: Tighter funding rounds and higher expectations Late-stage biotech startups—particularly those in Series B and beyond—face a more cautious funding environment Many investors are pulling back from large-scale growth funding due to concerns about biotech valuations, profitability, and exit opportunities This shift has





中文字典-英文字典  2005-2009